MedPath

Keppra

Brand Name: Keppra

Generic Name: Levetiracetam

Active
Registration Number

DR-XY29122

Dosage Form

Film-Coated Tablet

Issuance Date

December 31, 2022

Expiry Date

March 4, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 g
PackagingAluminum/PVC blister x 10's

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antiepileptic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

LevetiracetamActive
Monograph: Levetiracetam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform